Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myelogenous Leukemia
Reports summarize acute myelogenous leukemia study results from M. Mantzarides and co-researchers
March 18th, 2008
"Granulocytic sarcoma (GS) is a rare disease corresponding to extramedullary tumor mostly associated with acute myelogenous leukemia. Despite the aggressiveness of leukemic cells, F-18-FDG PET is not recommended for leukemia but it may have relevance for these tumors with solid and malignant organization," investigators in Paris, France report. "Two patients presented with acute myelogenous leukemia and GS. Every known malignant site showed significant uptake of F-18-FDG and we described many unknown locations. For 1 patient, PET revealed an important metabolic response after treatment and a relapse after few months," wrote M. Mantzarides and colleagues. ...
Source: Cancer Weekly (2008-03-18)
|
